Gut-Derived Metabolites Associated with Blood–Brain Barrier Alterations in Autistic Children: Preliminary Insights from a Sibling Pair Study
Microorganisms · 19.11.2026 · 14 (11) · 2697
DOI: 10.3390/microorganisms14112697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 19.11.2026. Verfasst von Luana Aldegheri und 8 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Autism spectrum disorder (ASD) frequently co-occurs with gastrointestinal symptoms, motivating the investigation of microbial and metabolic factors within the microbiota–gut–brain axis. However, the effects of participant-derived faecal preparations on brain endothelial barrier properties remain incompletely characterised. This exploratory study combined gut and oral microbiota profiling, faecal metabolomics, and an endothelial resistance assessment in four sibling pairs discordant for ASD. Microbiota were analysed using 16S rRNA gene sequencing, and untargeted HPLC-ESI/HRMS metabolomics was performed in two sibling pairs. Faecal cell-free supernatants were tested in human brain microvascular endothelial cells using electrical resistance measurements complemented by an ATP-based viability assay. Participant-level microbial profiles showed substantial heterogeneity, and several differences apparent in group averages were not consistently reproduced across sibling pairs. Putatively annotated metabolic features were assigned to tryptophan-related pathways and the superpathway of chorismate metabolism; chorismate itself was not detected. Supernatants from the ASD participants in two of four pairs produced lower normalised endothelial resistance than the corresponding sibling control specimens, whereas this pattern was not observed in the other two pairs. No apparent reduction in ATP-based viability was observed at the measured endpoint. These findings integrate microbial and metabolic profiling with a functional endothelial assessment relevant to blood–brain barrier (BBB) research but do not establish an ASD-specific signature, BBB dysfunction, or a causal microbiota–metabolite–barrier mechanism. Larger, prospectively characterised cohorts and the controlled validation of candidate bioactive components are required.
Förderung
- Italian Ministry of Health
Zitieren
APA
Aldegheri, L., Kharrat, F., Ardizzoni, A., Pedretti, N., Zadini, A., Mione, F., Pericolini, E., Caporali, A., & Comar, M. (2026). Gut-Derived Metabolites Associated with Blood–Brain Barrier Alterations in Autistic Children: Preliminary Insights from a Sibling Pair Study. Microorganisms, 14(11), 2697. https://doi.org/10.3390/microorganisms14112697
Vancouver
Aldegheri L, Kharrat F, Ardizzoni A, Pedretti N, Zadini A, Mione F, et al. Gut-Derived Metabolites Associated with Blood–Brain Barrier Alterations in Autistic Children: Preliminary Insights from a Sibling Pair Study. Microorganisms. 2026;14(11):2697. doi:10.3390/microorganisms14112697
BibTeX
@article{Aldegheri2026,
author = {Aldegheri, Luana and Kharrat, Feras and Ardizzoni, Andrea and Pedretti, Natalia and Zadini, Antonella and Mione, Francesca and Pericolini, Eva and Caporali, Andrea and Comar, Manola},
title = {Gut-Derived Metabolites Associated with Blood–Brain Barrier Alterations in Autistic Children: Preliminary Insights from a Sibling Pair Study},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2697},
doi = {10.3390/microorganisms14112697}
}
EUVIMED